Health Condition 1: C50- Malignant neoplasm of breast
Conditions
Interventions
Intervention1: PATIENT EDUCATION: In the intervention group, apart from the care offered by the physician, study pharmacist will analyze the patient drug therapy and will provide counseling on various
Sponsors
Self funded
Eligibility
Inclusion criteria
Inclusion criteria: Female patients with 18 years of age and above diagnosed with breast cancer without metastasis and admitted to receive first cycle of chemotherapy.
Exclusion criteria
Exclusion criteria: Patients who are not willing to participate in the study. Mentally challenged patients Patients who are not able to speak
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient information leaflet for breast cancer patients will be prepared and validatedTimepoint: Patient information leaflet will be prepared and validated within 6 months of commencement of study (Within January 2021) | — |
Secondary
| Measure | Time frame |
|---|---|
| Impact of pharmaceutical care provided by the clinical pharmacist in improving the quality of life of breast cancer patients will be studied. Impact of clinical pharmacist medication counseling on medication adherence among breast cancer patients will be analyzed.Timepoint: It will be evaluated after the completion of data collection and followup which is expected to be completed by February 2022 | — |
Countries
India
Contacts
Public ContactDr JUNO J JOEL
NGSM INSTITUTE OF PHARMACEUTICAL SCIENCES
Outcome results
None listed